Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment
Crossref DOI link: https://doi.org/10.1007/s13300-019-0591-9
Published Online: 2019-03-07
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brooks, Anne
Langer, Jakob
Tervonen, Tommi
Hemmingsen, Mads Peter
Eguchi, Kosei
Bacci, Elizabeth Dansie
Funding for this research was provided by:
Novo Nordisk
Article History
Received: 18 December 2018
First Online: 7 March 2019